• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Pharmaceuticals from a coal mine?

Bioengineer by Bioengineer
February 6, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Digging around in the dark can sometimes lead to interesting results: in the acidic waters of an abandoned coal mine in Kentucky (USA), researchers discovered ten previously unknown microbial natural products from a strain of Streptomyces. They have now introduced these compounds in the journal Angewandte Chemie. Four of the molecules contain a cyclopentenone ring, which is rare in this class of substances.

The team led by Khaled A. Shaaban and Jon S. Thorson at the University of Kentucky (UK)'s Center for Pharmaceutical Research and Innovation (Lexington, USA) is part of a broader new initiative focused on mining-associated environments in Appalachian Kentucky. The goal is to seek out new organisms that produce previously unknown metabolites that could be potential starting materials for pharmaceutical development.

The team has discovered previously unknown metabolites of a strain of Streptomyces in the abandoned underground Rock Creek coal mine in McCreary County. These compounds belong to the family of ansamycins, compounds that contain an aromatic ring system bridged by a long, aliphatic chain. The geldanamycins (Gdm) are a subset of the ansamycins whose aromatic ring consists of a quinone group, a six-membered ring of carbons with two double bonds and two oxygen atoms attached by double bonds. Gdm inhibits heat shock protein 90 (Hsp 90), a protein important for cell survival. Various Gdm analogs are in clinical use as antitumor drugs.

Characterization of the new compounds revealed that six of them are previously unknown geldanamycin variants. Four others are a new type of ansamycin: Instead of an aromatic ring, they have a cyclopentenone group, a ring of five carbons with a double bond and one oxygen atom bound by a double bond. These new compounds were named McCrearamycins after their county of origin.

The researchers speculate that Gdms could be precursors of the McCrearamycins. Experiments with Gdms and model substances revealed that the quinone group can easily be converted to a cyclopentenone via a benzylic acid rearrangement. This could be a new synthetic route for the production of cyclopentenone derivatives.

Along with three known Gdm derivatives, the new compounds were tested for their ability to inhibit Hsp 90 and to probe their cytotoxicity against a line of cancer cells. The two did not correlate in all cases. It is clear that small structural variations can give rise to differences in cell uptake and/or different cytotoxicity mechanisms. This is worth examining further in the development of new pharmaceuticals.

In collaboration with S. Randal Voss and UK's Ambystoma Genetic Stock Center, researchers also validated a new test for the activity of Hsp 90. The Mexican axolotl (Ambystoma mexicanum) is able to regenerate damaged limbs. Hsp 90 plays an important role in this process. In the presence of massive doses of Gdm, the amputated tails of axolotl embryos were not able to regenerate. High doses also caused developmental abnormalities. Gdm is thus useful for investigating the role of Hsp 90 in regeneration processes, and the test is useful in the search for Hsp 90 modulators.

###

About the Author

Dr. Jon Thorson is Professor of Pharmaceutical Sciences in the University of Kentucky (UK) College of Pharmacy and Director of the UK Center for Pharmaceutical Research and Innovation. His main specialty is biocatalyst and natural product-based lead discovery. Dr. Thorson also serves as the co-Director of UK's Markey Cancer Center's Drug Discovery, Delivery and Translational Therapeutics Program and co-Director of the Drug Discovery and Development Core in the UK Center for Clinical and Translational Science.

http://pharmacy.uky.edu/faculty/jth238/Jon-Thorson

Media Contact

Mario Mueller
[email protected]

http://www.wiley.com/wiley-blackwell

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Study by SFU and Wageningen University Links River Widening to Increased Severity of Floods

October 7, 2025

Reelin: A Promising Protein for Gut Repair and Depression Treatment

October 7, 2025

FIU Cybersecurity Experts Unveil Midflight Defense Mechanism to Prevent Drone Hijacking

October 7, 2025

UBCO Study Reveals Sex Education Falls Short for 2SLGBTQIA+ Students

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    888 shares
    Share 355 Tweet 222
  • New Study Reveals the Science Behind Exercise and Weight Loss

    98 shares
    Share 39 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    94 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    76 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study by SFU and Wageningen University Links River Widening to Increased Severity of Floods

Reelin: A Promising Protein for Gut Repair and Depression Treatment

FIU Cybersecurity Experts Unveil Midflight Defense Mechanism to Prevent Drone Hijacking

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.